ACTIVITY AND ANTIGEN OF SARUPLASE AND 2 CHAIN UROKINASE RELATED PLASMINOGEN-ACTIVATOR ARE STABILIZED BY A COMBINATION OF APROTININ AND BENZAMIDINE IN CITRATED PLASMA

被引：9
|
作者：
GUNZLER, WA
BEIER, H
FLOHE, L
机构：
[1] W.A. Günzler, H. Beier, L. Flohé, Grünenthal GmbH, Center of Research, Aachen
来源：
FIBRINOLYSIS | 1990年 / 4卷
关键词：
Aprotinin; Benzamidine; rscu-PA; Saruplase; Stabilizing agents; tcu-PA; Tranexamic acid;
D O I：
10.1016/0268-9499(90)90393-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Complete recovery of rscu-PA- and /or tcu-PA-activity or antigen as measured by Immune Activity Assay or by ELISA respectively, requires citrated plasma containing benzamidine and aprotinin. © 1990.
引用
收藏
页码：145 / 147
页数：3
相关论文
共 50 条
  • [1] IDENTIFICATION OF 2 TYPES OF UROKINASE RELATED PLASMINOGEN-ACTIVATOR ACTIVITY IN HUMAN-PLASMA
    BINNEMA, DJ
    DOOIJEWAARD, G
    VANIERSEL, JJL
    [J]. THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 103 - 103
  • [2] DIFFERENTIAL DETECTION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND 2 CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN AND MONKEY PLASMA
    MOLINARI, A
    GIORGETTI, C
    BONOMINI, L
    GERNA, M
    LANSEN, J
    GUREWICH, V
    [J]. FIBRINOLYSIS, 1992, 6 (01) : 17 - 26
  • [3] DIFFERENTIAL DETECTION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND 2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN AND MONKEY PLASMA
    MOLINARI, A
    GIORGETTI, C
    BONOMINI, L
    GERNA, M
    LANSEN, J
    GUREWICH, V
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1268 - 1268
  • [4] PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 PREVENTS ACTIVATION OF SINGLE CHAIN UROKINASE TYPE PLASMINOGEN-ACTIVATOR IN PLASMA
    DOSNE, AM
    SAMAMA, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1273 - 1273
  • [5] CIRCADIAN FLUCTUATIONS IN PLASMA-LEVELS OF TISSUE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY
    HUBER, K
    BECKMANN, R
    LANG, I
    SCHUSTER, E
    BINDER, BR
    [J]. FIBRINOLYSIS, 1989, 3 (01) : 41 - 43
  • [6] IMPORTANCE OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) FOR PREVENTING SINGLE CHAIN UROKINASE PLASMINOGEN-ACTIVATOR (SCU-PA) CONVERSION INTO 2 CHAIN UROKINASE PLASMINOGEN-ACTIVATOR (TCU-PA) IN PLASMA INVITRO
    DOSNE, AM
    DUBOR, F
    SAMAMA, M
    [J]. THROMBOSIS RESEARCH, 1991, 63 (05) : 531 - 539
  • [7] COMPARISON OF PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY AND ANTIGEN IN PLASMA SAMPLES
    URDEN, G
    HAMSTEN, A
    WIMAN, B
    [J]. CLINICA CHIMICA ACTA, 1987, 169 (2-3) : 189 - 196
  • [8] ANTIGEN LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN CITRATED PLASMA - DETERMINATION OF THE CONTRIBUTION OF PLATELETS
    GRIMAUDO, V
    BACHMANN, F
    KRUITHOF, EKO
    [J]. HAEMOSTASIS, 1990, 20 (06) : 329 - 333
  • [9] A MONOCLONAL-ANTIBODY SPECIFIC FOR 2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - APPLICATION TO THE STUDY OF THE MECHANISM OF CLOT LYSIS WITH SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PLASMA
    DECLERCK, PJ
    LIJNEN, HR
    VERSTREKEN, M
    MOREAU, H
    COLLEN, D
    [J]. BLOOD, 1990, 75 (09) : 1794 - 1800
  • [10] ENHANCEMENT OF THE ENZYMATIC-ACTIVITY OF SINGLE-CHAIN UROKINASE PLASMINOGEN-ACTIVATOR BY SOLUBLE UROKINASE RECEPTOR
    HIGAZI, AA
    COHEN, RL
    HENKIN, J
    KNISS, D
    SCHWARTZ, BS
    CINES, DB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) : 17375 - 17380
12345